Using point-of-care CD34 enumeration to optimize PBSC collection conditions

References

• Civin CI, Strauss LC, Brovall C, Fackler MJ. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cell. y Immunol 1984;133:157–65.
   Google Scholar
• Civin CI, Banquerigo ML, Strauss LC, Loken MR. Antigenic analysis of hematopoeisis. VI. Flow cytometric characterization of My-10-positive progenitor cells in nor-mal human bone marrow. Exp Hematol 1987;15:10–6.
   Google Scholar
• Sutherland DR, Keating A. The CD34 antigen: structure, biology and potential clinical applications. 7 Hematother 1992;1:115–29.
   PubMedGoogle Scholar
• Berenson RJ, Bensinger WI, Hill RS et al. Engraftment afterinfusion of CD 34+ marrow cells in patients with breast can-cer or neuroblastoma. Blood 1991;77:1717–22.
   PubMed Web of Science ®Google Scholar
• Civin CI, Trishmann T, Kadan NS et al. Highly purified CD 34-positivecells reconstitute hematopoiesis. 7 Gun Oncol 1996;14:2224�33.
   Google Scholar
• Shpall EJ, Jones RB. Mobilization and collection of periph-eral blood progenitor cells for support of high-dose cancer therapy. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific, 1994:913�8.
   Google Scholar
• Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723�7.
   Google Scholar
• Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ periph-eral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998;8: 84�92.
   Google Scholar
• Glaspy JA, Shpall EJ, LeMaistre CF et al. Peripheral bloodprogenitor cell mobilization using stem cell factor in com-bination with filgrastim in breast cancer patients. Blood 1997; 90:2939�51.
   Google Scholar
• Schulman KA, Birch R, Zhen B et al. Effect of CD34+ cell dose on resource utilization in patients after high dose chemotherapy with peripheral blood stem cell support. J Clin Oncol 1999;14:1227�33.
   Google Scholar
• Read EJ, Kunitake ST, Carter CS et al. Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry. J Hemathother 1997;6:291�301.
   Google Scholar
• Siena S, Bregni M, Brando B et al. Flow cytometry for clini-cal estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400–9.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for C D34+ cell determination by flow cytometry. Hematother 1996;5:213–26.
   PubMedGoogle Scholar
• Johnsen HE, Knudsen LM [for the Nordic Stem Cell Laboratory Group (NSCL-G)]. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leuka-pheresis products [Report from the Second Nordic Workshop]. yHematother 1996;5: 237–45.
   Google Scholar
• Schepers KG, Davis JM, Eby LL, Noga SJ. Comparison of progenitor cell assays (PC A) for the quality control of bone marrow (BM) [Abstract] 45th Annual Meeting, AABB, San Francisco, CA, Nov, 1992.
   Google Scholar
• Noga SJ, Grayson C, Noffsinger L et al. Sequential periph-eral blood (PB) measurement of CD34 using the IMAGN 2000 microvolume fluorimeter optimizes peripheral blood stem cell (PBSC) collection schedules. Blood 1998;92:3046.
   Google Scholar
• Shpall EJ, Champlin R, Glaspy JA. Effect of CD 34 periph-eral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998;4: 84–92.
   Google Scholar
• Mavroudis D, Read E, Cottler-Fox M et al. CD34+ cell dose predicts survival, post-transplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996;88:3223–9.
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Takaue Y, S aito S. Toxicities associated with cry-opreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993;33:578–81.
   Google Scholar
• Serke S, Johnsen H, Huhn D, Kvalheim G. European survey of the flow cytometric determination of CD34-expressing cells. Cytotherapy 1999;1:343–7.
   PubMedGoogle Scholar
• Brecher M, Sims L, Schmitz J. North American multicenter study on flow cytometric enumeration of C D34+ hematopoietic stem cells. 7 Hematother 1996;5: 227–36.
   Google Scholar